- International Name: DEXAMETHAZONE; NEOMTCIN; POLYMYXIN B
- Pharmacological group: Combined antibacterial and anti-inflammatory drug for topical use in ophthalmology.
- Manufacturer: Alcon Belgium
- Issuance form: Group III over-the-counter
Maxitrol (dexamethasone 0.1%, neomycin sulfate, polymyxin B sulfate) is an anti-inflammatory and antimicrobial drug in the form of a sterile suspension and ointment for topical use.
Ophthalmic drug maksitroli contains two, the action of a wide range of antibiotics corticosteroid combination, which gives the eye the previous segment of bacterial infections in the treatment method.
Corticosteroids suppress the inflammatory response, although they may inhibit wound healing because they are known to have the ability to weaken the body's defenses in some cases. At this time it is necessary to prescribe antimicrobials.
The antimicrobial ingredients in the drug act on the following microorganisms: neomycin sulfate - Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae;
Polymyxin B - is active against gram-negative bacteria: Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa.
Resistant to a given antibiotic: Streptococcus spp., Including. Streptococcus pneumoniae, and anaerobic bacteria
The combination of a corticosteroid and an antibiotic is highly practical for patients. The relative activity of corticosteroids depends on their molecular structure.
Maxitrol is used in inflammatory processes of the eye, when it is necessary to conduct joint antimicrobial and glucocorticoid therapy.
Directions and dosage:
1-2 drops in the eyes. In acute forms of the disease can be instilled every 1 hour. As the condition improves, the frequency of taking the drug decreases until it is completely removed.
Prolonged ongoing processes are prescribed 4-5 times a day.
Maxitrol ointment is applied 3-4 times a day.
Allergic reactions - associated with hypersensitivity to the components of the drug;
Increased intraocular pressure, rarely - subcapsular cataract;
Delayed wound healing, secondary infections.
* Keratitis caused by Herpes simplex;
* A number of viral diseases of the cornea and conjunctiva;
* Fungal diseases of the eye;
Hypersensitivity to any component of the drug;
* The drug is categorically contraindicated when removing a foreign body from the cornea.
* With prolonged use it is possible to develop glaucoma, damage to the optic nerve, decreased visual acuity, reduced visual field, as well as further development of subcapsular cataracts.
* Prolonged use may suppress the patient's immune system, increasing the risk of developing a secondary infection.
* In acute purulent processes of the eye, the drug may mask or complicate the course of the infectious process. If corticosteroids are used for more than 10 days, regular monitoring of intraocular pressure is required.
The drug is stored at room temperature, out of reach of children.
Conditions of release: Out of prescription.